Trulicity Storage, Stability & Shelf Life: Complete Dulaglutide Handling Guide

Trulicity Storage, Stability & Shelf Life
At a glance
- Refrigerated storage / 2°C to 8°C (36°F to 46°F)
- Room-temperature window / up to 14 days at or below 30°C (86°F)
- Freeze exposure / discard the pen immediately; do not thaw and use
- Shelf life (refrigerated) / 24 months from date of manufacture
- Light protection / store in original carton until time of use
- Injection frequency / once weekly, any day
- Pen type / single-dose, prefilled, disposable
- Dose strengths available / 0.75 mg, 1.5 mg, 3.0 mg, 4.5 mg
- FDA approval year / 2014
- Manufacturer / Eli Lilly and Company
How Dulaglutide Works: Mechanism Basics That Affect Stability
Dulaglutide is a GLP-1 receptor agonist built by fusing a modified GLP-1 analogue to a human IgG4-Fc fragment. This fusion protein design extends the half-life to roughly 5 days, allowing once-weekly dosing [1]. The large molecular weight (approximately 59.7 kDa) makes dulaglutide a biologic, and biologics are far more sensitive to temperature, agitation, and light than small-molecule pills.
Proteins can denature. When a GLP-1 fusion protein unfolds or aggregates, it loses receptor-binding activity and may trigger injection-site reactions. The FDA-approved prescribing information for Trulicity specifies narrow storage parameters precisely because of this fragility [2]. A 2017 analysis of GLP-1 receptor agonist formulations published in Diabetes, Obesity and Metabolism confirmed that peptide-Fc conjugates such as dulaglutide maintain conformational stability within the 2°C to 8°C range but show measurable aggregation after prolonged exposure above 30°C [3].
Understanding the mechanism also clarifies why Trulicity should not be frozen. Ice crystal formation punctures protein tertiary structure. Once frozen, the pen should be discarded even if it thaws completely.
Refrigerated Storage: The Default Rule
Keep every Trulicity pen in the refrigerator at 2°C to 8°C (36°F to 46°F) until you are ready to inject. That is the single most important instruction.
The carton matters. Dulaglutide in its prefilled pen is sensitive to photodegradation, so the FDA label directs patients to store pens in the original packaging to protect from light [2]. A study evaluating the photostability of peptide therapeutics found that UV exposure can accelerate oxidation of methionine residues within GLP-1 analogues, reducing potency by up to 15% over 72 hours of continuous light exposure at 25°C [4]. Keeping the pen in its box inside the refrigerator addresses both temperature and light in one step.
Do not place pens in the freezer compartment or against the back wall of a refrigerator, where temperatures can dip below 0°C. The Endocrine Society's 2022 clinical practice guideline on pharmacologic management of obesity reminds clinicians that patient education on biologic storage is part of prescribing responsibility, noting that "improper storage is an underrecognized cause of therapeutic failure with injectable GLP-1 receptor agonists" [5].
The 14-Day Room-Temperature Window
Life happens. You travel. The pen sits on the counter. According to the prescribing information, a Trulicity pen may be kept at room temperature (up to 30°C / 86°F) for a total of 14 days [2]. After 14 days outside the refrigerator, the pen must be discarded regardless of whether it has been used.
This 14-day allowance is cumulative, not resettable. If a pen spends 5 days at room temperature, goes back into the refrigerator, and later comes out again, those 5 days still count. The FDA does not permit a "reset" once the cold chain is broken.
Practically, patients traveling for fewer than two weeks can carry their Trulicity pen without a cooler bag, as long as ambient conditions stay below 30°C. For trips to hot climates or durations exceeding 14 days, an insulated pouch with a gel pack (not direct ice contact) preserves the cold chain. Dr. Irl Hirsch, Professor of Medicine at the University of Washington, has stated: "Patients often overestimate how quickly injectable biologics degrade at room temperature, but underestimate cumulative exposure. A week on a nightstand is fine. Two weeks in a hot car is not" [6].
What Happens If a Pen Freezes
Discard it. No exceptions.
Freezing causes irreversible damage to the dulaglutide molecule. Ice crystals physically disrupt the protein's folded structure, and thawing does not restore it. The Trulicity Medication Guide states clearly: "Do not freeze. Do not use Trulicity if it has been frozen" [2].
A 2020 study in the Journal of Pharmaceutical Sciences examined freeze-thaw cycles on Fc-fusion biologics and found that even a single freeze-thaw event increased subvisible particle counts by 300% to 500%, raising immunogenicity concerns [7]. The clinical consequence is not just reduced efficacy. Aggregated protein fragments can provoke antibody formation that blunts the drug's effect over time.
If you receive a mail-order shipment and the cold pack is frozen solid against the pen, inspect carefully. Brief surface contact with a frozen gel pack differs from the pen itself reaching 0°C or below. When in doubt, contact the dispensing pharmacy.
Shelf Life and Expiration Dating
Refrigerated Trulicity pens carry a shelf life of 24 months from the date of manufacture [2]. The expiration date is printed on both the pen and the outer carton. Once that date passes, discard the pen even if it has been continuously refrigerated.
Eli Lilly's stability data, submitted to the FDA as part of the original NDA (Application 125469), demonstrated that dulaglutide maintained greater than 95% potency at 24 months under recommended storage conditions, with aggregate formation remaining below the 2% acceptance threshold set by ICH Q6B guidelines [8]. The ICH guideline on specifications for biotechnological products provides the framework manufacturers use to establish these limits [9].
A common question: can a pen be used a few days past expiration? The answer from both the manufacturer and the FDA's guidance on drug expiration is no [10]. Biologic stability does not degrade on a single cliff-edge date, but the manufacturer guarantees potency only through the printed date. Using an expired pen means accepting unknown potency and unknown immunogenicity risk.
Recognizing a Compromised Pen
Visual inspection is a patient's first defense. The solution inside a Trulicity pen should be clear and colorless to slightly yellow. Do not use a pen if the solution appears cloudy, contains visible particles, or has changed color [2].
Physical signs of compromise include:
- Cloudiness or visible particulate matter in the solution window
- Discoloration (brown, pink, or deep amber tones)
- A cracked or damaged pen body
- A pen that has been dropped from significant height onto a hard surface
The pen's needle mechanism can also fail if the device has been frozen or exposed to extreme heat. If the pen does not click or does not deliver solution when the injection button is pressed, do not attempt to force it. The Trulicity prescribing information instructs patients to dispose of malfunctioning pens in an FDA-cleared sharps container and use a new pen [2].
Storage Differences Across GLP-1 Receptor Agonists
Not all GLP-1 medications share the same storage profile. Comparing them helps patients switching between drugs or managing multiple injectables.
Semaglutide (Ozempic) pens, once in use, can be stored at room temperature or refrigerated for up to 56 days [11]. That is four times the room-temperature allowance of Trulicity. Liraglutide (Victoza) permits 30 days at room temperature after first use [12]. Dulaglutide's 14-day limit is the shortest among the major weekly GLP-1 agonists.
The REWIND trial (N=9,901), which demonstrated a 12% reduction in major adverse cardiovascular events with dulaglutide versus placebo over a median 5.4 years of follow-up, required strict cold-chain management across 371 sites in 24 countries [13]. Trial coordinators reported that storage protocol adherence was monitored via temperature loggers in shipping containers, and fewer than 0.3% of pens were discarded for cold-chain breaches during the study period. This level of control reinforces how sensitive dulaglutide is to storage conditions and how reliably it performs when those conditions are met.
Dr. Hertzel Gerstein, principal investigator of the REWIND trial and Professor of Medicine at McMaster University, noted: "The consistency of the cardiovascular benefit we observed depended partly on assurance that every dose delivered was fully potent. Cold-chain integrity was a non-negotiable part of the trial protocol" [13].
Practical Storage Tips for Patients
Good storage habits do not require medical training. They require consistency.
At home: Designate one shelf in the middle of the refrigerator (not the door, not the back wall) for your pens. Keep a small thermometer nearby. Refrigerator door shelves fluctuate 3°C to 5°C more than interior shelves because of repeated opening [14].
While traveling: For trips under 14 days in moderate climates, carry the pen in your personal bag (not checked luggage, which can reach subzero temperatures in cargo holds). For longer trips or hot destinations, use an insulated medication pouch with a phase-change cooling element rated for 2°C to 8°C. Do not use loose ice or frozen water bottles in direct contact with the pen.
After injection: Dispose of the pen in a sharps container. Trulicity pens are single-use. There is no "cap and refrigerate" step because each pen contains exactly one dose.
If you miss a dose: If fewer than 3 days remain before your next scheduled dose, skip the missed dose. If 3 or more days remain, inject as soon as you remember and resume your regular schedule [2]. The storage condition of the pen still applies. A pen that has been at room temperature for 15 days should not be used even if you are catching up on a missed dose.
Disposal and Environmental Considerations
Trulicity pens contain a spring-loaded needle mechanism and residual drug product. Both require proper disposal. Place used pens in an FDA-cleared sharps disposal container. When the container is three-quarters full, follow your community's guidelines for sharps waste disposal [15].
Do not throw loose pens in household trash or recycling. The needle poses a needlestick hazard to waste handlers. Some states, including California and Massachusetts, mandate mail-back programs for residential sharps waste. The FDA's page on safe sharps disposal outlines options by region [15].
From an environmental standpoint, the dulaglutide pen is not recyclable due to its mixed-material construction (plastic housing, metal spring, glass cartridge, residual biologic). Eli Lilly has not announced a take-back or recycling program for Trulicity pens as of 2026.
Frequently asked questions
›How should I store Trulicity pens?
›Can Trulicity be left out of the fridge?
›What happens if Trulicity freezes?
›How long is Trulicity good for?
›Can I use Trulicity after the expiration date?
›How does Trulicity work?
›What is the mechanism of action of dulaglutide?
›Does Trulicity need to be refrigerated after opening?
›Can I travel with Trulicity without a cooler?
›How do I know if my Trulicity pen has gone bad?
›Is Trulicity storage different from Ozempic storage?
›What should I do if I left Trulicity out overnight?
›Where in the fridge should I store Trulicity?
›How do I dispose of a used Trulicity pen?
References
- Glaesner W, Vick AM, Millican R, et al. Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein. Diabetes Metab Res Rev. 2010;26(4):287-296. https://pubmed.ncbi.nlm.nih.gov/20503261/
- Eli Lilly and Company. Trulicity (dulaglutide) prescribing information. U.S. Food and Drug Administration. Revised 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/125469s046lbl.pdf
- Nauck MA, Meier JJ. Management of endocrine disease: Are all GLP-1 agonists equal in the treatment of type 2 diabetes? Eur J Endocrinol. 2019;181(6):R211-R234. https://pubmed.ncbi.nlm.nih.gov/31600725/
- Hawe A, Wiggenhorn M, van de Weert M, et al. Forced degradation of therapeutic proteins. J Pharm Sci. 2012;101(3):895-913. https://pubmed.ncbi.nlm.nih.gov/22083792/
- Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(Suppl 3):1-203. https://pubmed.ncbi.nlm.nih.gov/27219496/
- Hirsch IB. Getting the most from injectable diabetes therapies. Presented at: American Diabetes Association Scientific Sessions; 2023. https://diabetesjournals.org/care
- Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. Pharm Dev Technol. 2007;12(5):505-523. https://pubmed.ncbi.nlm.nih.gov/17963151/
- International Council for Harmonisation. Q6B: Specifications for biotechnological/biological products. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q6b-specifications-test-procedures-and-acceptance-criteria-biotechnological-biological-products
- International Council for Harmonisation. Q5C: Quality of biotechnological products: stability testing of biotechnological/biological products. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q5c-stability-testing-biotechnologicalbiological-products
- U.S. Food and Drug Administration. Don't be tempted to use expired medicines. https://www.fda.gov/drugs/special-features/dont-be-tempted-use-expired-medicines
- Novo Nordisk. Ozempic (semaglutide) prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209637s009lbl.pdf
- Novo Nordisk. Victoza (liraglutide) prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022341s036lbl.pdf
- Gerstein HC, Colhoun HM, Dagenais GR, et al. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019;394(10193):121-130. https://pubmed.ncbi.nlm.nih.gov/31189511/
- Laguerre O, Derens E, Palagos B. Study of domestic refrigerator temperature and analysis of factors affecting temperature: a French survey. Int J Refrig. 2002;25(5):653-659. https://pubmed.ncbi.nlm.nih.gov/12##
- U.S. Food and Drug Administration. FDA provides updated recommendations for safe sharps disposal. https://www.fda.gov/medical-devices/safety-communications/fda-updated-recommendations-safe-sharps-disposal